Yes-associated protein-1 may serve as a diagnostic marker and therapeutic target for residual/recurrent hepatocellular carcinoma post-transarterial chemoembolization(☆)

BACKGROUND AND AIM: The transcriptional co-activator Yes-associated protein-1 (YAP1) has been implicated as an oncogene and is overexpressed in different kinds of human cancers, especially hepatocellular carcinoma (HCC). However, the role of YAP1 has not been reported in residual/recurrent HCC after...

Descripción completa

Detalles Bibliográficos
Autores principales: Qian, Xia, Zhang, Wei, Shams, Alireza, Mohammed, Kahee, Befeler, Alex S., Kang, Ningling, Lai, Jinping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7842263/
https://www.ncbi.nlm.nih.gov/pubmed/33520338
http://dx.doi.org/10.1016/j.livres.2020.11.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7842263/
https://www.ncbi.nlm.nih.gov/pubmed/33520338
http://dx.doi.org/10.1016/j.livres.2020.11.002

Ejemplares similares